APELLIS PHARMACEUTICALS, INC.: financing cash flow

What this measure means

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Exact concept: us-gaap:NetCashProvidedByUsedInFinancingActivities. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2016-01-01 to 2025-12-31. The SEC response was captured on 2026-09-21.

Selected filing history

Related financial histories

• APELLIS PHARMACEUTICALS, INC.: total assets
• APELLIS PHARMACEUTICALS, INC.: total liabilities
• APELLIS PHARMACEUTICALS, INC.: stockholders equity
• APELLIS PHARMACEUTICALS, INC.: cash and cash equivalents
• APELLIS PHARMACEUTICALS, INC.: net income or loss
• APELLIS PHARMACEUTICALS, INC.: operating cash flow
• APELLIS PHARMACEUTICALS, INC.: capital expenditure payments
• APELLIS PHARMACEUTICALS, INC.: contract revenue excluding tax
• APELLIS PHARMACEUTICALS, INC.: investing cash flow
• APELLIS PHARMACEUTICALS, INC.: retained earnings or deficit
• APELLIS PHARMACEUTICALS, INC.: basic weighted-average shares
• APELLIS PHARMACEUTICALS, INC.: diluted weighted-average shares
• APELLIS PHARMACEUTICALS, INC.: basic earnings per share
• APELLIS PHARMACEUTICALS, INC.: diluted earnings per share
• APELLIS PHARMACEUTICALS, INC.: income tax expense or benefit
• APELLIS PHARMACEUTICALS, INC.: net property, plant and equipment
• APELLIS PHARMACEUTICALS, INC.: share-based compensation expense
• APELLIS PHARMACEUTICALS, INC.: operating income or loss
• APELLIS PHARMACEUTICALS, INC.: current assets
• APELLIS PHARMACEUTICALS, INC.: current liabilities
• APELLIS PHARMACEUTICALS, INC.: current accounts payable
• APELLIS PHARMACEUTICALS, INC.: net current accounts receivable
• APELLIS PHARMACEUTICALS, INC.: operating expenses
• APELLIS PHARMACEUTICALS, INC.: net inventory
• APELLIS PHARMACEUTICALS, INC.: selling, general and administrative expense
• APELLIS PHARMACEUTICALS, INC.: research and development expense
• APELLIS PHARMACEUTICALS, INC.: common shares outstanding
• APELLIS PHARMACEUTICALS, INC.: cash including restricted cash
• APELLIS PHARMACEUTICALS, INC.: additional paid-in capital
• APELLIS PHARMACEUTICALS, INC.: accumulated other comprehensive income or loss
• APELLIS PHARMACEUTICALS, INC.: operating lease right-of-use asset
• APELLIS PHARMACEUTICALS, INC.: operating lease liability
• APELLIS PHARMACEUTICALS, INC.: long-term debt
• APELLIS PHARMACEUTICALS, INC.: other noncurrent assets
• APELLIS PHARMACEUTICALS, INC.: other noncurrent liabilities
• APELLIS PHARMACEUTICALS, INC.: accrued current liabilities
• APELLIS PHARMACEUTICALS, INC.: pre-tax income or loss from continuing operations
• APELLIS PHARMACEUTICALS, INC.: profit or loss including noncontrolling interests
• APELLIS PHARMACEUTICALS, INC.: comprehensive income or loss
• APELLIS PHARMACEUTICALS, INC.: general and administrative expense
• APELLIS PHARMACEUTICALS, INC.: depreciation expense
• APELLIS PHARMACEUTICALS, INC.: nonoperating interest expense
• APELLIS PHARMACEUTICALS, INC.: other nonoperating income or expense
• APELLIS PHARMACEUTICALS, INC.: current income tax expense or benefit
• APELLIS PHARMACEUTICALS, INC.: interest paid, net
• APELLIS PHARMACEUTICALS, INC.: income taxes paid, net
• APELLIS PHARMACEUTICALS, INC.: proceeds from issuing common stock
• APELLIS PHARMACEUTICALS, INC.: operating lease payments
• APELLIS PHARMACEUTICALS, INC.: change in accounts receivable
• APELLIS PHARMACEUTICALS, INC.: change in inventories
• APELLIS PHARMACEUTICALS, INC.: change in accounts payable

Inspect the source

Entity

APELLIS PHARMACEUTICALS, INC. / CIK 0001492422

Captured

2026-09-21T17:19:23.869Z

SEC response SHA-256

d855a4e81b3da8707e343214abe406f3014a2ed6d4ac72156c893608477710a5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001492422.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))